Hospital Council Shifts Focus to Support Foundation's Goals

San Antonio Healthcare & Bioscience Magazine

The HC+B Newsletter	January 28, 2010

in this issue

:: GSAHC Shifts Focus

:: BioMed SA Expands Executive Committee, Elects New Members & Officers

:: UTHSCSA Aids Development

:: Medtronic Hires Renowned Cardiologist

:: START Enrolls First Patient in Phase I Clinical Trial

:: About InnoTech Symposium

:: SFBR Dedicated Building to Dr. Rao

Dear HC+B Readers,

Welcome to the new and improved format of The HC+B Newsletter.

This new look, the first of a series of changes soon to include the website and the magazine (digital issue), comes at the heels of a new year and a rapidly changing landscape in the field of healthcare and technology. It is my intent to continue keeping you abreast of these changes as well as the activities of our local healthcare and

life sciences community.

Stay tuned for exciting updates as well as a sneak peak

on topics for the upcoming Spring Issue of the S.A. HC+B Magazine which is slowly morphing into a fabulous "focus on healthcare design

& construction" issue. Look for the Spring issue early March!

Best regards,

Melba Romero

Publisher/Editor

S.A. HC+B Magazine

Hospital Council Shifts Focus to Support Foundation's Goals

The Board of Directors of the Greater San Antonio Hospital Council has formally re-aligned its strategic vision to focus on the critical healthcare workforce issues facing the San Antonio region.

BioMed SA Expands Executive Committee, Elects New Members and Officers

BioMedSA

BioMed SA, the non-profit organization charged with promoting San Antonio's healthcare and bioscience industry, has re-elected officers for 2010 and expanded its Executive Committee to 19 members by adding an additional seat for bioscience firms and a new seat for venture capital/investors.

Micro-thermostat Controls Infection Tied to Common AIDS Cancer

A tiny molecule called a microRNA acts as a thermostat regulating infection by the Kaposi's sarcoma-associated herpesvirus, researchers at The University of Texas Health Science Center at San Antonio reported this week in Nature Cell Biology.

Medtronic Hires Renowned Cardiologist as Vice President of Medical Affairs for Coronary and Peripheral Business

A tiny molecule called a microRNA acts as a Medtronic, Inc. (NYSE: MDT), recently announced the hire of Prof. Martin Rothman as vice president of medical affairs for the company's coronary and peripheral vascular business based in Santa Rosa, Calif.

First Patient Enrolled In Phase I Clinical Trial Of Landmark Astrazeneca, Merck & Co. Novel Combination Anticancer Regimen

Dr. Tolcher

Dr. Anthony Tolcher, clinical director for South Texas Accelerated Research Therapeutics (START) at the START Center for Cancer Care in San Antonio, announced recently that the first patient has been enrolled in a groundbreaking Phase I clinical trial of a novel combination anticancer regimen composed of two investigational compounds: MK-2206 from Merck & Co., Inc. and AZD6244 (ARRY-886*) from AstraZeneca.

Emerging Medical Technical Symposium Held in conjunction with InnoTech San Antonio

The Emerging Medical Technology Symposium at InnoTech San Antonio is presenting a half-day event focusing on the challenges of conceiving, developing, and bringing medical products to market by providing education, networking opportunities, and access to investor resources.

Southwest Foundation For Biomedical Research Dedicates Building Wing In Honor Of Pemmaraju N. Rao, Expert In Women's Health Research

Earlier this month, the Southwest Foundation for Biomedical Research (SFBR) dedicated a section of a building on its campus in honor of Pemmaraju N. Rao, Ph.D., an invaluable member of the SFBR community for 51 years.

If you or your organization has an announcement or release that you would like to submit for editorial consideration for the newsletter or magazine, please send all inquiries to Melba Romero at hcbmag@sbcglobal.net.